Watchlist Price Alert

BioMarin Pharmaceutical I... (BMRN)

NASDAQ: BMRN · Real-Time Price · USD

61.32

2.46 (4.18%)

At close: May 12, 2025, 3:59 PM

63.50

3.56%

After-hours: May 12, 2025, 06:24 PM EDT

BioMarin Pharmaceutical Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	2.85B	2.42B	2.1B	1.85B	1.86B	1.7B	1.49B	1.31B	1.12B
Cost of Revenue	580.24M	577.07M	483.67M	470.51M	524.27M	359.47M	315.26M	241.79M	209.62M
Gross Profit	2.27B	1.84B	1.61B	1.38B	1.34B	1.34B	1.18B	1.07B	907.23M
Operating Income	484.21M	194.44M	57.55M	-60.01M	-96.26M	-125.46M	-123.52M	-14.7M	-803.43M
Interest Income	74.88M	58.34M	18.03M	10.48M	16.61M	22.75M	22.83M	14.85M	7.49M
Pretax Income	541.76M	188.56M	149.58M	-75.35M	-42.32M	-94.81M	-142.71M	-35.88M	-831.05M
Net Income	426.86M	167.65M	141.56M	-64.08M	854.03M	-23.85M	-77.21M	-117.04M	-630.21M
Selling & General & Admin	1.01B	937.3M	854.01M	759.38M	737.67M	680.92M	604.35M	554.34M	476.59M
Research & Development	747.18M	746.77M	649.61M	628.79M	628.12M	715.01M	696.33M	610.75M	661.9M
Other Expenses	33.28M	n/a	67.19M	69.93M	66.66M	74.11M	2.21M	7.97M	4.93M
Operating Expenses	1.79B	1.75B	1.57B	1.46B	1.43B	1.47B	1.35B	1.21B	1.11B
Interest Expense	12.67M	17.34M	15.97M	15.34M	29.31M	23.46M	43.66M	42.71M	39.5M
Selling & Marketing Expenses	476.7M	488.4M	450.3M	405.1M	403.4M	n/a	n/a	n/a	n/a
Cost & Expenses	2.37B	2.27B	2.05B	1.93B	1.96B	1.83B	1.66B	1.45B	1.32B
Income Tax Expense	114.9M	20.92M	8.02M	-11.27M	-901.42M	-70.96M	-65.49M	81.17M	-200.84M
Shares Outstanding (Basic)	190.03M	187.83M	185.27M	182.85M	180.8M	179.04M	177.06M	174.43M	165.99M
Shares Outstanding (Diluted)	196.71M	191.59M	188.96M	182.85M	191.68M	179.04M	177.27M	174.43M	166.22M
EPS (Basic)	2.13	0.89	0.76	-0.35	4.75	-0.13	-0.44	-0.67	-3.8
EPS (Diluted)	2.06	0.87	0.75	-0.35	4.53	-0.13	-0.44	-0.67	-3.79
EBITDA	650.86M	310.28M	267.51M	48.03M	-5.85M	33.95M	-3.54M	94.76M	-705.53M
EBIT	554.1M	205.3M	164.95M	-60.61M	-21.52M	-73.38M	-99.04M	3.11M	-794.92M
Depreciation & Amortization	96.43M	104.39M	101.97M	108.04M	105.88M	105.3M	95.5M	87.92M	86.03M